Dr Maria Konstandi received her PhD in Neuropharmacology in 1985 from the National and Kapodistrian University of Athens, Schools of Medicine and Pharmacy, Athens-Greece. She had a post doctoral training in Pharmacokinetics, “Agia Sofia” Hospital, Athens, Greece; Neurochemistry, University of Kuopio, Finland; Brain Dialysis, C.N.R.S.,/I.N.S.E.R.M., College de France, Paris, France; Enzymology and Molecular Pharmacology, IARC/WHO, Lyon, France and Karolinska Institutet, Stockholm-Sweden; Animal Models of Experimental Schizophrenia, Neuroscience Center at St. Elizabeth’s, NIMH, Bethesda, MD, USA; Metabolomics and Gene Regulation in the Laboratory of Metabolism, NCI/NIH, Bethesda, MD, USA. Dr Konstandi’s research focuses mainly on the mechanisms underlying the effect of psychophysiological stress on various drug metabolizing systems. In addition, her research team investigates the role of natural products in lipid homeostasis and cardioprotection. Emphasis is given on the role of PPARs. The goal of these studies is the identification of the mechanisms mediating these effects and the synthesis of new molecules with possible applications in the treatment of related diseases. Dr Konstandi is also involved on a regular basis in the teaching of the courses of Pharmacology, Drugs of Abuse, Development of New Drugs and Clinical Pharmacology, offered to the medical students of the University of Ioannina. Since 2000, she has acted as supervisor in five doctoral dissertations in the fields of Neuropharmacology, Molecular Toxicology, Lipid and Drug Metabolism. For her studies Dr Konstandi has received funding from National and European research programmes (EPEAEK ΙΙ, PENED, ERDF etc). She is a member of several scientific organizations: International Brain Research Organization (IBRO), International Union of Pharmacology (IUPHAR), Greek Society of Pharmacology, European Biochemistry Organization (EBO), International Society for the studies of Xenobiotics (ISSX).